TLDR The FDA said it won’t enforce certain food and drug laws against hemp-derived oral CBD products Cannabis stocks had their best week of 2026, with the sectorTLDR The FDA said it won’t enforce certain food and drug laws against hemp-derived oral CBD products Cannabis stocks had their best week of 2026, with the sector

These Cannabis Stocks Just Had Their Best Week of the Year — Here’s Why

2026/04/03 17:50
3분 읽기
이 콘텐츠에 대한 의견이나 우려 사항이 있으시면 crypto.news@mexc.com으로 연락주시기 바랍니다

TLDR

  • The FDA said it won’t enforce certain food and drug laws against hemp-derived oral CBD products
  • Cannabis stocks had their best week of 2026, with the sector ETF up 16%
  • Tilray, Canopy Growth, and Curaleaf all posted strong gains Thursday
  • The move follows Trump’s December executive order reclassifying marijuana as Schedule III
  • Analysts say the policy is still narrow and stops short of a full regulatory framework

Cannabis stocks posted their strongest gains of the year this week after the FDA announced a softer stance on CBD products. The move sent several major cannabis names sharply higher and put the sector on track for its best weekly performance since December.

FDA Commissioner Marty Makary said in a letter Wednesday that the agency will not enforce certain provisions of the Federal Food, Drug, and Cosmetic Act against hemp-derived oral products simply because they contain CBD. The policy applies to products marketed as dietary supplements and those provided to patients under a doctor’s direction.

CBD is a non-psychoactive compound found in cannabis. It is used for a range of health-related purposes and is found in many consumer wellness products.

The rally in cannabis stocks began Tuesday, one day before the White House and FDA kicked off a series of four meetings with industry stakeholders to discuss CBD compliance and enforcement policy.

The FDA’s new position builds on President Trump’s executive order from December, which moved marijuana from Schedule I to Schedule III under federal drug law. That order also directed the FDA, the National Institutes of Health, and the Centers for Medicare and Medicaid Services to develop ways to expand access to CBD for medical use.

Cannabis stocks briefly rallied after that December order before falling back. The sector has long faced problems with banking access, stock listings, and interstate commerce due to federal restrictions.

Tilray Brands

Tilray was one of the top movers this week. Its stock rose 6.7% on Thursday alone and was among the highest by dollar trading volume in the cannabis sector. The company researches, grows, processes, and distributes medical cannabis across multiple countries including Canada, Germany, Australia, and Argentina.


TLRY Stock Card
Tilray Brands, Inc., TLRY

Canopy Growth

Canopy Growth rose 2.6% Thursday. The company sells cannabis and hemp products for both recreational and medical use in the US, Canada, Germany, and other international markets. It also operates the Storz and Bickel segment, which makes cannabis vaporizers. Canopy was flagged alongside Tilray as one of the most actively traded cannabis stocks this week.


CGC Stock Card
Canopy Growth Corporation, CGC

Curaleaf Holdings

Curaleaf was the strongest performer among the major names on Thursday, jumping 8.4%. The company is a US-focused cannabis operator. Its shares have been among the most watched in the sector as investors track any shift in federal policy that could open up interstate commerce for cannabis businesses.

The AdvisorShares Pure US Cannabis exchange-traded fund rose 4.6% Thursday and gained 16% for the week, putting it on pace for its best weekly performance since December.

One industry analyst noted the policy is “narrowly scoped” and stops short of building a lasting framework for the broader cannabis market, calling on Congress to take further action.

The FDA held its first stakeholder meeting on CBD policy on Wednesday, with three more scheduled as part of the same series.

The post These Cannabis Stocks Just Had Their Best Week of the Year — Here’s Why appeared first on CoinCentral.

시장 기회
Orderly Network 로고
Orderly Network 가격(ORDER)
$0.0355
$0.0355$0.0355
+4.10%
USD
Orderly Network (ORDER) 실시간 가격 차트

World Cup Combo: Aim for 200x

World Cup Combo: Aim for 200xWorld Cup Combo: Aim for 200x

Combine up to 20 World Cup matches in one order

면책 조항: 본 사이트에 재게시된 글들은 공개 플랫폼에서 가져온 것으로 정보 제공 목적으로만 제공됩니다. 이는 반드시 MEXC의 견해를 반영하는 것은 아닙니다. 모든 권리는 원저자에게 있습니다. 제3자의 권리를 침해하는 콘텐츠가 있다고 판단될 경우, crypto.news@mexc.com으로 연락하여 삭제 요청을 해주시기 바랍니다. MEXC는 콘텐츠의 정확성, 완전성 또는 시의적절성에 대해 어떠한 보증도 하지 않으며, 제공된 정보에 기반하여 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다.